HCM Summit VI offers attendees an opportunity to learn the clinical, morphologic, and genetic spectrum of hypertrophic cardiomyopathy (HCM) from a renowned international faculty. We will explore a detailed contemporary view of HCM in which improved diagnostic techniques and management strategies have reduced disease mortality and vastly improved thousands of patients’ lives.
- Practicing cardiologists, internists, pediatricians, nurses and other healthcare professionals with an interest in HCM.
- Residents, fellows, and medical students.
- Clinicians and basic researchers directly involved with HCM
Learner Objectives / Outcomes
- Choose contemporary management strategies for high-risk and other patient subgroups, including: surgical septal myectomy, alcohol septal ablation, and prevention of sudden death with implantable defibrillators.
- Outline the causes of sudden death in competitive athletes and the profile of HCM in athlete populations.
- Outline the pros and cons of different mas screening strategies for detecting HCM in general populations.
- Interpret new advances in drug treatment, relief of LV outflow obstruction with novel operative or percutaneous techniques and the potential application of systems biology and personalized medicine to HCM.
- Identify HCM’s clinical, morphologic, and genetic spectra.
- Understand the natural history, clinical course, and overall disease burden of HCM.
- Review contemporary management strategies including surgical septal myectomy, alcohol septal ablation, and sudden death prevention through implantable defibrillators.
- Assess and determine appropriate advanced heart failure management and selection of patients for heart transplant.
- Understand atrial fibrillation’s disease burden and contemporary management strategies.
- Explore mechanisms responsible for adverse clinical events and natural history.
- Learn the roles of advanced diagnostic modalities including magnetic resonance imaging (MRI) and novel echocardiographic techniques.
- Understand the clinical significance and occurrence of left ventricular out ow obstruction (at rest and with provocation), and the natural history of patients without obstruction.
- Learn competitive athlete sudden death causes and HCM profile in athlete populations.
- Understand the pros and cons of mass screening strategies to detect HCM in general populations.
- Discover key technologic developments in diagnosis, sudden death risk assessment, and myocardial fibrosis detection with contrast MRI.
- Learn new advances in drug treatment, animal models, and LV out ow obstruction relief via novel operative or percutaneous techniques.
- Explore the potential applications of systems biology, personalized medicine, and dedicated worldwide HCM Centers (including those in developing countries).
This activity is designed to address the following ACGME/ABMS and IOM competencies:
- Medical/clinical knowledge
- Patient care